Additional studies in immune competent mouse models would be necessary to assess the role of B7-H3 as an immune checkpoint protein and the potential of B7-H3 inhibition to promote both the anti-tumor immune response and sensitivity to chemotherapy in melanoma. Here, CD276 is linked to melanoma.